chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After the vaccine by May 7th, I had a rash from my collar bone to my belly button and all over my back as well, I also had a fever. On Nov 6th, I started to have symptoms of COVID-19 with a minor sore throat, and the next day I almost vomited because of the smells I was smelling and tested positive on Nov. 8, 2021. On the 9th, I received the anti-bodies and I started feeling better, I had a fever of about 101 for about 5 days, and I chills and body aches. I was having a lot of fatigue for at least 13 days, I was also in quarantine for 13 days, COVID-19 and shortness of breathe for up to six weeks after COVID-19. I could not do my normal duties. I tried to get an inhaled steroid from my Dr. but it took a while for me to receive it. The first inhaler given did not work Nov 19 it was albuterol but it did not help, and then a different Dr. prescribed Flovent on Dec 16, I used that for a few weeks and the shortness of breath started to get better.
Pt. received vaccines and was fine as nurse left the room with pt in mom's care. I entered room after loud bang heard and pt on the floor. Mom stated she passed our and fell face first into the floor. Pt with syncope and lying face up with cut on forehead crying saying teeth felt funny and head and nose hurt. Forehead with cut and gaping nasal bridge swollen and lower central incisor with chips to see dentist and nasal films. Kept in office x 1 hour til able to walk out. VSS.
Almost immediate "glazing" of eyes. Coughing attack within 40 minutes and hives noticed widespread by 1 1/2-2 hours later.
Patient states c/o numbness/tingling to his face s/p 2 hrs prior to vaccine administration on 8/19/2013. Patient called this author 8/20/13 to c/o continued numbness tingling rash to left side of body - and was advised to ER.
FELT A LITTLE BIT NAUSEOUS; TOOK VIVOTIF WHICH STORED AT 30 DEGREES FARHEINITE; This spontaneous case report was received from a nurse (PVX2019-420) on 13-Feb-2019. The report describes a female consumer who felt a little bit nauseous following the intake of Vivotif for an unknown indication. The consumer also "took Vivotif which stored at 30 degrees Fahrenheit".  The consumer had a history of tendonitis and motion sickness.  The consumer was not taking any concomitant medications.  It was reported that the consumer completed the doses of Vivotif, which were stored at 30 degree Fahrenheit. She also felt a little bit nauseous after her last dose.   The action taken with Vivotif with respect to the events felt a little bit nauseous and "took Vivotif which stored at 30 degrees Fahrenheit" was not applicable.  The clinical outcome of the event felt a little bit nauseous was resolved while with respect to the event "took Vivotif which stored at 30 degrees Fahrenheit" was unknown.  Company's comment:  In this case, the consumer developed "little bit nauseous" following administration of Vivotif. The event was reported with reasonable time relationship to intake of the vaccine. Hence, the causality of the event "little bit nauseous" with Vivotif was assessed as possible. The causality of the event "took Vivotif which stored at 30 degrees Fahrenheit" was considered as not applicable.; Sender's Comments: Company's comment:  In this case, the consumer developed "little bit nauseous" following administration of Vivotif. The event was reported with reasonable time relationship to intake of the vaccine. Hence, the causality of the event "little bit nauseous" with Vivotif was assessed as possible. The causality of the event "took Vivotif which stored at 30 degrees Fahrenheit" was considered as not applicable.
Throughout 2020 and prior to injection clean bill of health even though I continued to fly and stay overnight in hotels. Once I was vaccinated, experienced fever, chills, sore muscles and achy joints. On or about 2 March 2021 started experiencing intense diahrea, and vomiting, which is ongoing even today. Although the vomiting had stopped.
date of onset unk-unable contact mom--fever began 10/8 & 10/9; h/a & sz w/o fever 10/16;adm to hosp 10/16/99; still @ UKMC as of 10/25; 60 day follow-up dated 8/17/0 provided no additional data. Annual follow-up dated 1/29/01 provided no additional data.
Ongoing neuropathy that began after my flu shot in 2017 became significantly worse about 36 hours after the COVID vaccine.  This neuropathy had no physical cause when it began in 2017 other than it began about 36 hours after my flu shot.  Over the course of 3 years while taking Lyrica the pain decreased substantially.  It is now approaching it highest levels from 3 years ago 8 days after the COVID vaccine.
Headache, Arthralgia, Sore throat Narrative:  Feeling yuck day after injection, injection site still red and sore several days after injection
Patient seen 10/12/15 with onset of rash 10/9/15; had measles like rash that started on face and spread to body.
Pt requested medical consultation and I and paramedics arrived to assess.  Pt has hx mast cell activation, in consultation with allergist took Benadryl, cromolyn sodium and Pepcid 1 hour prior to vaccination. 20 minutes after vaccination had pink puffiness of lower eyelids bilat and had GI bloating, no SOB/wheeze/tongue or throat swelling but elected to self-administer own Epi-Pen to prevent progression to anaphylaxis that has started with similar sxs in past. Exam: CV RRR no M slight tachycardia, bp 150/73 HR 107 RR 99. Pt observed for 10 minutes with no progression of sxs and advised to wait additional 15 minutes to ensure she was feeling well enough to drive home.
stiff; My arm was also very red; I had real bad body aches.; Severe Chills; fever of 103; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff), ERYTHEMA (My arm was also very red), CHILLS (Severe Chills), PYREXIA (fever of 103) and MYALGIA (I had real bad body aches.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Compazine.) and Allergy to vaccine (Allergy to vaccine shingles shot.). Concomitant products included SIMVASTATIN (ZOCOR), METFORMIN HCL, ESTRADIOL (YUVAFEM), METOPROLOL SUCCINATE (TOPROL XL) and TRAVOPROST for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced CHILLS (Severe Chills) and PYREXIA (fever of 103). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff), ERYTHEMA (My arm was also very red) and MYALGIA (I had real bad body aches.). At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff), ERYTHEMA (My arm was also very red), CHILLS (Severe Chills), PYREXIA (fever of 103) and MYALGIA (I had real bad body aches.) outcome was unknown.            No Treatment Medications were reported. Severe Chills and Fever lasted about two days. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-029489 (Patient Link).
pt recv vax 1aUG95 & 1DEC96 approx 2wk p/being exposed to chickenpox pt exp six spots;
pt recvd vax; 1 1/2 hrs later started crying; cried all noc;
Received vaccine on 12/30; tested positive for Covid19 on 1/6.
Caller reports dose of PNEUMOVAX 23 was administered intramuscular in Gluteus Maximus.  No other information provided.  No additional AEs or PQC reported.; No additional AEs or PQC reported; This spontaneous report was received from nurse, referring to a 66-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient received a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 milliliter (ml), administered intramuscularly (IM) in gluteus maximus, as prophylaxis, (strength and vaccination scheme frequency were not provided; lot number T031820 that was verified to be valid for syringe formulation with an expiration date not reported but upon internal validation established as 10-MAY-2022) (product administered at inappropriate site). No other information provided. No adverse events (AEs) (no adverse event) were reported.
Patient presents in the office today with wheezing. Not really congested today. Mom reminds me that she had a bad reaction after the rotavirus vaccine with becoming weak, pale, diaphoretic, lethargic that evening. At first just fussy and acted like she didn't feel well, wanted to sleep, after a few hours she woke up but then became very limp and almost completely unresponsive. Parents became alarmed and prepared to go to the ER but then the child began to cry and respond to stimuli so they didn't go.
No adverse effects; A 52 years old patient was inadvertentlyadministered a dose of PROQUAD instead of M-M-R II; A 52 years old patient was inadvertentlyadministered a dose of PROQUAD instead of M-M-R II; This spontaneous report was received from a medical assistant regarding a 52-year-old patient. The patient's concurrent conditions, drug reactions/allergies, medical history and concomitant therapies were not reported.  On 25-APR-2019, the patient was administered inadvertently Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) subcutaneous lot number R013126 and expiration date 04-NOV-2019 (dosage was not reported) for prophylaxis instead of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (Inappropriate age at vaccine administration ) and (Wrong vaccine administered ). No adverse effects were reported. The sterile diluent was reported.
This was a vaccine error, not an adverse event. The nurse reconstituted yellow fever with sterile water instead of sodium chloride. According to CDC and Sanofi Pasteur  this renders the vaccine ineffective. Patient notified and aware.
Myalgia, Fatigue Narrative: Missed a few hours of work following the first dose on the day of administration
very sore muscles all down left arm but also sore muscles in knees, lower legs, right shoulder area
AREA AROUND THE INJECTION SITE IS WARM TO TOUCH; ITCHING IN ARM; red remark; injection which is hot to the touch and it hurts; AREA AROUND INJECTION SITE IS RED; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (AREA AROUND THE INJECTION SITE IS WARM TO TOUCH), PRURITUS (ITCHING IN ARM), VACCINATION SITE ERYTHEMA (red remark), VACCINATION SITE PAIN (injection which is hot to the touch and it hurts) and VACCINATION SITE ERYTHEMA (AREA AROUND INJECTION SITE IS RED) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (AREA AROUND THE INJECTION SITE IS WARM TO TOUCH), PRURITUS (ITCHING IN ARM), VACCINATION SITE ERYTHEMA (red remark), VACCINATION SITE PAIN (injection which is hot to the touch and it hurts) and VACCINATION SITE ERYTHEMA (AREA AROUND INJECTION SITE IS RED). At the time of the report, VACCINATION SITE WARMTH (AREA AROUND THE INJECTION SITE IS WARM TO TOUCH), PRURITUS (ITCHING IN ARM), VACCINATION SITE ERYTHEMA (red remark), VACCINATION SITE PAIN (injection which is hot to the touch and it hurts) and VACCINATION SITE ERYTHEMA (AREA AROUND INJECTION SITE IS RED) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant products were not provided. Treatment medication were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Reporter's details, Patient's age, Patient route of administration, Vaccination site warmth, Vaccination site erythema and Pruritus events were added.
Patient suffered rashes on her legs accompanied by easy bruising whereafter she was hospitalized and diagnosed with severe idiopathic thrombocytopenic purpura.; Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication.  On 07-JUL-2016, the patient was inoculated with a dose of zoster vaccine live (ZOSTAVAX) (lot number, expiration date, dosage and route of administration not provided), for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  Shortly after receiving the zoster vaccine live (ZOSTAVAX), the patient suffered rashes on her legs accompanied by easy bruising whereafter she was hospitalized on unspecified dates and diagnosed with severe idiopathic thrombocytopenic purpura.  As a direct and proximate result of the zoster vaccine live (ZOSTAVAX) vaccine, the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. Patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. The outcome of the idiopathic thrombocytopenic purpura was unknown.The reporter considered the vaccination with zoster vaccine live (ZOSTAVAX) to be related to the idiopathic thrombocytopenic purpura. Upon internal review the idiopathic thrombocytopenic purpura was consider as medically significant event.
Vaccination was given too low by technician. Patient was complaining of arm pain and pain shooting down her arm.
had Pain around the titanium rod in leg; This case was reported by a physician via call center representative and described the occurrence of leg pain in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included internal fixation of fracture (Titanium Rod in leg).   On 10th January 2021, the patient received the 1st dose of Shingrix (intramuscular). On 11th January 2021, 1 days after receiving Shingrix, the patient experienced leg pain. On an unknown date, the outcome of the leg pain was unknown.   It was unknown if the reporter considered the leg pain to be related to Shingrix.  Additional details were reported as follows: The patient was a physician. The patient received 1st dose of Shingrix and on the next day, the patient had pain around the titanium rod in leg upon awakening. The patient disconnected the call early due to time restraints, so all information was not available.
vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of adminstration".  Patient reported no adverse reactions.
On 2-16-10 Pt began with fever. Pt went into seizure became unresponsive was intubated. Pt was observed, tx and released.
Pt c/ dizziness 10mins post vaccination which then increased 5mins later.  Pt attributed dizziness to pain from menses. Vitals: @15:10 BP 120/62, HR 71, RR 18, O2 Sat 100% -- > @15:20 115/81, 79, 18, 100% Encouraged oral fluid intake.  Pt stable and released from the vaccination site @15:22 accompanied by husband.
I got sick to the point where I had to go to the Doctor. Coughing, post nasal drip, sore throat, body ache. They did a rapid and 3day covid test, strep throat and flu nasal swap - negative
Very fatigued for about 5 weeks.  A positive reaction is that psoriasis greatly subsided.
Red rash on face.  At first, 1/13/21, I didn't think it was related to the vaccine.  It spread and worsened over the next four days and then the injection site became red also that was when I related it to the vaccine, 1/18/21.  I sent a picture to my doctor, a friend, who retired, and he said to take Benadryl and Pepcid AC, which I did for 3 days (1/18/21 - 1/10/21).  I now have just a little roughness to my face and a very pale red mark by the injection site.
Severe global joint pain that lasted 5-6 weeks Menstral cycle that started 10 days early Random nose bleed
Information has been received from a female with a history of shingles about 10 years ago who in approximately June 2010, about 6 months ago, was vaccinated with a dose of ZOSTAVAX (Merck). In approximately June 2010, since receiving the vaccine, the patient had gotten more outbreaks of shingles that affect her right eye. The patient sought unspecified medical attention. At the time of this report, the outcome was unknown. No further information is available.
Client was called prior to appointment and left message due to client being under the age requirement for Pfizer vaccine.  On date of appointment, client arrived to clinic with mother and was vaccinate with Dose 1 of Pfizer. Client did not qualify due to be under the age requirement.
On the arm of injection (the left arm), there was shoulder muscle pain, pain to bicep, tenderness and swelling of the skin at the bicep area, pink flushed color in bicep area and darker pink color around the area of the left arm above the elbow.
Patient reports her atopic dermatitis symptoms started "a few weeks" after her Moderna COVID-19 booster, which was administered on 11/11/2021. Pt states symptoms started under her armpits and face then spread to her hands.
Follow up appt. 11-09-16 10:30 A.M everything was fine. Since I had not had my flu shot Nurse came in and injected right arm. Enclosed is copy of my previous shots without problems. I have never had such pain - swelling in my arms and now Dr. wants me to have MRI on my shoulder but I feel all of this is from the vaccine or the way it was given.
can't move; has not been eating or drinking anything; been week; diarrhea; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (can't move), FEEDING DISORDER (has not been eating or drinking anything), ASTHENIA (been week), DIARRHOEA (diarrhea) and VOMITING (throwing up) in an 87-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    In September 2023, the patient received fourth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 04-Oct-2023, the patient experienced MOBILITY DECREASED (can't move), FEEDING DISORDER (has not been eating or drinking anything), ASTHENIA (been week), DIARRHOEA (diarrhea) and VOMITING (throwing up). At the time of the report, MOBILITY DECREASED (can't move), FEEDING DISORDER (has not been eating or drinking anything) and ASTHENIA (been week) outcome was unknown and DIARRHOEA (diarrhea) and VOMITING (throwing up) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.  Patient has received 3 doses of the Moderna COVID-19 vaccines before receiving a dose of the SPIKEVAX vaccine on either 26-SEP-2023 or 27-SEP-2023. Lot number unknown. Since yesterday he has been throwing up, had diarrhea, been week, can't move, and has not been eating or drinking anything.   He has not taken any medications or treatments for his symptoms. He has not spoken to his healthcare professional.
ADMINISTERED EXPIRED VACCINE; This spontaneous report received from a pharmacist concerned multiple patients. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, and batch number: 1808982 expiry: 21-SEP-2021) dose was not reported, administered on 28-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 28-SEP-2021, the patient experienced administered expired vaccine. The action taken with covid-19 vaccine was not applicable. The outcome of administered expired vaccine was not reported. This report was non-serious.
pain at the injection sight; This case was reported by a other health professional via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 27-Jul-2022. Reporter's Comments: This case was reported by the other health professional via interactive digital media. The patient got the vaccine after a gentle scolding from a family member wondering why he/she had not since it was available to him/her. The patient was spurred on. 1. the fact that she had shingles and could not get vaccinated because too young.  2. ran into 2 of his/her patients with active shingles in the same week of the scolding. The patient figured someone was tried to tell something.  The patient tolerated the vaccine, slight pain at the injection site for a day or two, no big deal. Additional Supportive Information: The follow-up would not possible as no contact details were available.
Patient developed urticaria 2 hours after receiving vaccines. Pt received SOLUMEDROL 125mg IM & was started on a MEDROL dose pack. Pt was discharged in stable condition.
Patient presented to the ED and was subsequently hospitalized for Acute CVA (cerebrovascular accident) within 6 weeks of receiving COVID vaccination.
This patient had done the same thing, only he ended up taking pneumonia and dying with it; This is a spontaneous report from a contactable consumer or other non hcp. This is a split case report which was conservatively captured as per the statement 'This patient had done the same thing'. A 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced pneumonia on an unspecified date. It was reported that, when reporter saw her medical doctor, the day before reporting the event, who was very concerned because she had a recent patient that was about the same age as the reporter, he was 75 years old. The patient had done the same thing, only he ended up taking pneumonia and dying with it. The patient died on an unspecified date. It was not reported if an autopsy was performed. The outcome of the event was fatal on an unknown date.  Information about Lot/Batch number has been requested.; Reported Cause(s) of Death: This patient had done the same thing, only he ended up taking pneumonia and dying with it
This spontaneous report as received from a nurse practitioner via a company representative refers to a 58 years old female patient. The patient's medical history, drug reactions/allergies and concurrent conditions were not reported. On 23-APR-2015, the patient was vaccinated with PNEUMOVAX 23 (lot number L001311, expiration date 06-JUL-2016), 0.5 ml, intramuscular, 1 dose (anatomical location was not reported) for routine vaccination. On 23-APR-2015, the patient experienced pain in hr arm, her body was going numb and she had trouble moving after the vaccination with PNEUMOVAX 23. The patient was sent to the emergency room, and was treated with KENALOG and DEPO-MEDROL on an unspecified date. The patient sought medical attention thru office visit on an unspecified date. At the time of the report, the outcome of the pain in her arm, body was going numb and trouble moving was recovered/resolved on an unspecified date in 2015. Additional information has been requested.